Timing is more important than choice of agentBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1506a (Published 02 December 1995) Cite this as: BMJ 1995;311:1506
- Tom Sulkin, Registrar in general medicine
- Royal South Hants Hospital, Southampton SO14 0TG
EDITOR,--Marc Verstraete states incorrectly1 that the accelerated tissue plasminogen activator regimen used in the global utilisation of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) trial2 “lowered the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial